Pseudomonas aeruginosa DSM 102273 is a human pathogen that has multiple antibiotic resistances and was isolated from patient material.
antibiotic resistance human pathogen Bacteria| @ref 20215 |
Last LPSN update
2026-05-29 08:37:43 |
| Domain Bacteria |
| Phylum Pseudomonadota |
| Class Gammaproteobacteria |
| Order Pseudomonadales |
| Family Pseudomonadaceae |
| Genus Pseudomonas |
| Species Pseudomonas aeruginosa |
| Full scientific name Pseudomonas aeruginosa (Schroeter 1872) Migula 1900 (Approved Lists 1980) |
| Synonyms (2) |
| @ref | Name | Growth | Medium link | Composition | |
|---|---|---|---|---|---|
| 23675 | COLUMBIA BLOOD MEDIUM (DSMZ Medium 693) | Medium recipe at MediaDive  | Name: COLUMBIA BLOOD MEDIUM (DSMZ Medium 693) Composition: Defibrinated sheep blood 50.0 g/l Columbia agar base | ||
| 23675 | TRYPTICASE SOY YEAST EXTRACT MEDIUM (DSMZ Medium 92) | Medium recipe at MediaDive | Name: TRYPTICASE SOY YEAST EXTRACT MEDIUM (DSMZ Medium 92) Composition: Trypticase soy broth 30.0 g/l Agar 15.0 g/l Yeast extract 3.0 g/l Distilled water |
| @ref | Growth | Type | Temperature (°C) | |
|---|---|---|---|---|
| 23675 | positive | growth | 37 |
| Test 1 | Test 2 | Test 3 | Test 4 | |
|---|---|---|---|---|
| @ref | 23675 | 23675 | 23675 | 23675 |
| Medium | Mueller-Hinton Agar | Mueller-Hinton Agar | Mueller-Hinton Agar | Müller-Hinton Agar |
| Manual annotation | 1 | 1 | 1 | 1 |
| Inhibition zone diameter in mm | Inhibition zone diameter in mm | Inhibition zone diameter in mm | Inhibition zone diameter in mm | |
| Amikacin 30µg (disc) | 8 | 10-12 | 10-12 | 8 |
| Ampicillin 10µg (disc) | 0 | 0 | 0 | 0 |
| Aztreonam 30µg (disc) | 6 | 8-10 | 8-10 | 8-10 |
| Bacitracin 10Unit | 0 | 0 | 0 | n.d. |
| Cefalotin 30µg (disc) | 0 | 0 | 0 | n.d. |
| Cefazolin 30µg (disc) | 0 | 0 | 0 | n.d. |
| Cefiderocol 30µg (disc) | n.d. | n.d. | n.d. | 32 |
| Cefotaxime 30µg (disc) | 0 | 0 | 0 | 0 |
| Ceftazidime 10µg (disc) | n.d. | n.d. | n.d. | 0 |
| Ceftriaxone 30µg (disc) | 0 | 0 | 0 | 0 |
| Chloramphenicol 30µg (disc) | 10 | 0 | 0 | 10 |
| Ciprofloxacin 5µg (disc) | n.d. | n.d. | n.d. | 0 |
| Clindamycin 10µg (disc) | 0 | 0 | 0 | 0 |
| Colistin 10µg (disc) | 18 | 16 | 16 | n.d. |
| Colistin sulphate 10µg (disc) | n.d. | n.d. | n.d. | 18-20 |
| Doxycycline 30µg (disc) | 10 | 8-10 | 8-10 | n.d. |
| Erythromycin 15µg (disc) | 0 | 0 | 0 | 0 |
| Fosfomycin 50µg (disc) | 30 | 26-28 | 26-28 | 20 |
| Gentamicin 10µg (disc) | 0 | 0 | 0 | n.d. |
| Gentamicin 30µg (disc) | n.d. | n.d. | n.d. | 0 |
| Imipenem 10µg (disc) | 0 | 0 | 0 | 0 |
| Kanamycin 30µg (disc) | 0 | 0 | 0 | 0 |
| Levofloxacin 5µg (disc) | n.d. | n.d. | n.d. | 0 |
| Lincomycin 15µg (disc) | 0 | 0 | 0 | n.d. |
| Linezolid 10µg (disc) | 0 | 0 | 0 | 0 |
| Meropenem 10µg (disc) | n.d. | n.d. | n.d. | 0 |
| Mezlocillin 30µg (disc) | 0 | 0 | 0 | n.d. |
| Moxifloxacin 5µg (disc) | 0 | 0 | 0 | 0 |
| Neomycin 30µg (disc) | 6 | 10 | 10 | n.d. |
| Nitrofurantoin 100µg (disc) | 0 | 0 | 0 | 0 |
| Norfloxacin 10µg (disc) | 0 | 0 | 0 | n.d. |
| Nystatin 100Unit | 0 | 0 | 0 | n.d. |
| Ofloxacin 5µg (disc) | 0 | 0 | 0 | 0 |
| Oxacillin 5µg (disc) | 0 | 0 | 0 | 0 |
| Penicillin G 6µg (disc) | 0 | 0 | 0 | 0 |
| Pipemidic acid 20µg (disc) | 0 | 0 | 0 | n.d. |
| Piperacillin/Tazobactam 40µg (disc) | 6 | 6 | 6 | n.d. |
| Piperacillin/Tazobactam 110µg (disc) | n.d. | n.d. | n.d. | 6-8 |
| Polymyxin B 300Unit | 18-20 | 16-18 | 16-18 | 20-22 |
| Quinupristin/Dalfopristin 15µg (disc) | 0 | 0 | 0 | 0 |
| Rifampicin 5µg (disc) | n.d. | n.d. | n.d. | 6-8 |
| Teicoplanin 30µg (disc) | 0 | 0 | 0 | 8 |
| Tetracycline 30µg (disc) | 14-16 | 10 | 10 | 16-18 |
| Ticarcillin 75µg (disc) | 0 | 0 | 0 | 0 |
| Tigecycline 15µg (disc) | n.d. | n.d. | n.d. | 0 |
| Trimethoprim-sulfamethoxazole (1:19) 10µg (disc) | n.d. | n.d. | n.d. | 0 |
| Vancomycin 30µg (disc) | 0 | 0 | 0 | 0 |
| @ref | Chebi-ID | Metabolite | Utilization activity | Kind of utilization tested | |
|---|---|---|---|---|---|
| 68369 | 17128 ChEBI | adipate | + | assimilation | from API 20NE |
| 68368 | 27613 ChEBI | amygdalin | - | fermentation | from API 20E |
| 68369 | 29016 ChEBI | arginine | + | hydrolysis | from API 20NE |
| 68368 | 29016 ChEBI | arginine | + | hydrolysis | from API 20E |
| 68368 | 16947 ChEBI | citrate | + | assimilation | from API 20E |
| 68369 | 17634 ChEBI | D-glucose | + | assimilation | from API 20NE |
| 68369 | 17634 ChEBI | D-glucose | - | fermentation | from API 20NE |
| 68368 | 17634 ChEBI | D-glucose | - | fermentation | from API 20E |
| 68369 | 16899 ChEBI | D-mannitol | + | assimilation | from API 20NE |
| 68368 | 16899 ChEBI | D-mannitol | - | fermentation | from API 20E |
| 68369 | 27689 ChEBI | decanoate | + | assimilation | from API 20NE |
| 68369 | 5291 ChEBI | gelatin | - | hydrolysis | from API 20NE |
| 68368 | 5291 ChEBI | gelatin | - | hydrolysis | from API 20E |
| 68369 | 24265 ChEBI | gluconate | + | assimilation | from API 20NE |
| 68368 | 30849 ChEBI | L-arabinose | + | fermentation | from API 20E |
| 68368 | 62345 ChEBI | L-rhamnose | - | fermentation | from API 20E |
| 68368 | 25094 ChEBI | lysine | - | degradation | from API 20E |
| 68369 | 25115 ChEBI | malate | + | assimilation | from API 20NE |
| 68369 | 17306 ChEBI | maltose | - | assimilation | from API 20NE |
| 68368 | 28053 ChEBI | melibiose | + | fermentation | from API 20E |
| 68368 | 17268 ChEBI | myo-inositol | - | fermentation | from API 20E |
| 68369 | 59640 ChEBI | N-acetylglucosamine | + | assimilation | from API 20NE |
| 68369 | 17632 ChEBI | nitrate | + | reduction | from API 20NE |
| 68368 | 18257 ChEBI | ornithine | - | degradation | from API 20E |
| 68368 | 30911 ChEBI | sorbitol | - | fermentation | from API 20E |
| 68368 | 17992 ChEBI | sucrose | - | fermentation | from API 20E |
| 68369 | 27897 ChEBI | tryptophan | - | energy source | from API 20NE |
| 68368 | 27897 ChEBI | tryptophan | - | energy source | from API 20E |
| 68369 | 16199 ChEBI | urea | - | hydrolysis | from API 20NE |
| 68368 | 16199 ChEBI | urea | + | hydrolysis | from API 20E |
| @ref | ChEBI | Metabolite | Is resistant | Resistance conc. | |
|---|---|---|---|---|---|
| 23675 | 28971 | Ampicillin | 10 µg (disc) | from Antibiotic test | |
| 23675 | 28669 | Bacitracin | 10 Unit | from Antibiotic test | |
| 23675 | 124991 | Cefalotin | 30 µg (disc) | from Antibiotic test | |
| 23675 | 474053 | Cefazolin | 30 µg (disc) | from Antibiotic test | |
| 23675 | 204928 | Cefotaxime | 30 µg (disc) | from Antibiotic test | |
| 23675 | 3508 | Ceftazidime | 10 µg (disc) | from Antibiotic test | |
| 23675 | 29007 | Ceftriaxone | 30 µg (disc) | from Antibiotic test | |
| 23675 | 100241 | Ciprofloxacin | 5 µg (disc) | from Antibiotic test | |
| 23675 | 3745 | Clindamycin | 10 µg (disc) | from Antibiotic test | |
| 23675 | 48923 | Erythromycin | 15 µg (disc) | from Antibiotic test | |
| 23675 | 17833 | Gentamicin | 30 µg (disc) | from Antibiotic test | |
| 23675 | 17833 | Gentamycin | 10 µg (disc) | from Antibiotic test | |
| 23675 | 471744 | Imipenem | 10 µg (disc) | from Antibiotic test | |
| 23675 | 6104 | Kanamycin | 30 µg (disc) | from Antibiotic test | |
| 23675 | 63598 | Levofloxacin | 5 µg (disc) | from Antibiotic test | |
| 23675 | 6472 | Lincomycin | 15 µg (disc) | from Antibiotic test | |
| 23675 | 63607 | Linezolid | 10 µg (disc) | from Antibiotic test | |
| 23675 | 43968 | Meropenem | 10 µg (disc) | from Antibiotic test | |
| 23675 | 6919 | Mezlocillin | 30 µg (disc) | from Antibiotic test | |
| 23675 | 63611 | Moxifloxacin | 5 µg (disc) | from Antibiotic test | |
| 23675 | 71415 | Nitrofurantoin | 100 µg (disc) | from Antibiotic test | |
| 23675 | 100246 | Norfloxacin | 10 µg (disc) | from Antibiotic test | |
| 23675 | 7660 | Nystatin | 100 Unit | from Antibiotic test | |
| 23675 | 7731 | Ofloxacin | 5 µg (disc) | from Antibiotic test | |
| 23675 | 7809 | Oxacillin | 5 µg (disc) | from Antibiotic test | |
| 23675 | 18208 | Penicillin G | 6 µg (disc) | from Antibiotic test | |
| 23675 | 75250 | Pipemidic acid | 20 µg (disc) | from Antibiotic test | |
| 23675 | Quinupristin/Dalfopristin | 15 µg (disc) | from Antibiotic test | ||
| 23675 | 9587 | Ticarcillin | 75 µg (disc) | from Antibiotic test | |
| 23675 | 149836 | Tigecycline | 15 µg (disc) | from Antibiotic test | |
| 23675 | Trimethoprim-sulfamethoxazole (1:19) | 10 µg (disc) | from Antibiotic test | ||
| 23675 | 28001 | Vancomycin | 30 µg (disc) | from Antibiotic test |
| @ref | Value | Activity | Ec | |
|---|---|---|---|---|
| 68369 | arginine dihydrolase | + | 3.5.3.6 | from API 20NE |
| 68368 | arginine dihydrolase | + | 3.5.3.6 | from API 20E |
| 68368 | beta-galactosidase | - | 3.2.1.23 | from API 20E |
| 68369 | cytochrome oxidase | + | 1.9.3.1 | from API 20NE |
| 68368 | cytochrome oxidase | + | 1.9.3.1 | from API 20E |
| 68369 | gelatinase | - | from API 20NE | |
| 68368 | gelatinase | - | from API 20E | |
| 68368 | lysine decarboxylase | - | 4.1.1.18 | from API 20E |
| 68368 | ornithine decarboxylase | - | 4.1.1.17 | from API 20E |
| 68368 | tryptophan deaminase | - | 4.1.99.1 | from API 20E |
| 68369 | urease | - | 3.5.1.5 | from API 20NE |
| 68368 | urease | + | 3.5.1.5 | from API 20E |
| @ref | ONPG | ADH (Arg) | LDC (Lys) | ODC | CIT | H2S productionH2S | URE | TDA (Trp) | IND | Acetoin production (Voges Proskauer test)VP | GEL | GLU | MAN | INO | Sor | RHA | SAC | MEL | AMY | ARA | OX | Nitrite productionNO2 | Reduction to N2N2 | MotilityMOB | Growth on MacConkey mediumMAC | OF-O | OF-F | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 23675 | - | + | - | - | + | - | + | - | - | - | - | - | - | - | - | - | - | + | - | + | + | not determinedn.d. | not determinedn.d. | not determinedn.d. | not determinedn.d. | not determinedn.d. | not determinedn.d. |
| Topic | Title | Authors | Journal | DOI | Year | |
|---|---|---|---|---|---|---|
| Rutin/Sulfobutylether-beta-Cyclodextrin as a Promising Therapeutic Formulation for Ocular Infection. | De Gaetano F, Pastorello M, Pistara V, Rescifina A, Margani F, Barbera V, Ventura CA, Marino A. | Pharmaceutics | 10.3390/pharmaceutics16020233 | 2024 | | |
| Phenotype | Rapid Phenotypic Antibiotics Susceptibility Analysis by a 3D Printed Prototype. | Riester O, Kaiser L, Laufer S, Deigner HP. | Adv Sci (Weinh) | 10.1002/advs.202308806 | 2024 | |
| Antibacterial Nanoassembled Calix[4]arene Exposing Choline Units Inhibits Biofilm and Motility of Gram Negative Bacteria. | Consoli GML, Granata G, Ginestra G, Marino A, Toscano G, Nostro A. | ACS Med Chem Lett | 10.1021/acsmedchemlett.2c00015 | 2022 | | |
| Efficacy of Two Moroccan Cistus Species Extracts against Acne Vulgaris: Phytochemical Profile, Antioxidant, Anti-Inflammatory and Antimicrobial Activities. | Bouabidi M, Salamone FL, Gadhi C, Bouamama H, Speciale A, Ginestra G, Pulvirenti L, Siracusa L, Nostro A, Cristani M. | Molecules | 10.3390/molecules28062797 | 2023 | | |
| Studies on the Accumulation of Secondary Metabolites and Evaluation of Biological Activity of In Vitro Cultures of Ruta montana L. in Temporary Immersion Bioreactors. | Szewczyk A, Marino A, Taviano MF, Cambria L, Davi F, Trepa M, Grabowski M, Miceli N. | Int J Mol Sci | 10.3390/ijms24087045 | 2023 | |
How to citeIf you want to cite this particular strain cite the following doi:
https://doi.org/10.13145/bacdive131883.20260601.11
When using BacDive for research please cite the following paper
BacDive in 2025: the core database for prokaryotic strain data
License